A Study to Evaluate Antimalarial Activity and Safety of MK-7602 in Healthy Adults (MK-7602-003)
Clinical trial NCT06294912 · COMPLETED
Trial details
- NCT number
- NCT06294912
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-18
- Primary completion
- 2025-01-06
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.